Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohort

Affiliations

• ¹ Division of Rheumatology, McGill University Health Centre, Montreal, Quebec, Canada.
• ² Division of Clinical Epidemiology, Research Institute of the McGill University Health Center, Montreal, Quebec, Canada.
• ³ Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada.
• ⁴ Lupus Program, Centre for Prognosis Studies in the Rheumatic Disease and Krembil Research Institute, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada.
• ⁵ Division of Rheumatology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
• ⁶ Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición, Tlalpan, Mexico.
• ⁷ Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
• ⁸ Rheumatology Department, City Hospital, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK.
• ⁹ Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea.
• ¹⁰ Cedars-Sinai Medical Centre, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
• ¹¹ Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
• ¹² Division of Rheumatology, Department of Medicine, New York School of Medicine, New York City, New York, USA.
• ¹³ Department of Medicine, Centre for Rheumatology, University College London, London, UK.
• ¹⁴ Department of Medicine, SUNY Downstate Medical Center, Brooklyn, New York, USA.
• ¹⁵ Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
• ¹⁶ Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, North Carolina, USA.
• ¹⁷ Division of Rheumatology, Centre Hospitalier Universitaire de Québec et Université Laval, Québec City, Quebec, Canada.
• ¹⁸ Center for Rheumatology Research, Landspitali University Hospital, Reykjavik, Iceland.
• ¹⁹ Division of Rheumatology, Feinberg School of Medicine, Northwestern University Chicago, Chicago, Illinois, USA.
• ²⁰ Lupus Research Unit, The Rayne Institute, St Thomas' Hospital, King's College London School of Medicine, London, UK.
• ²¹ Lupus Center of Excellence, Feinstein Institute for Medical Research, Manhasset, New York, USA.
• ²² Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
• ²³ Lupus Center of Excellence, Allegheny Health Network, Pittsburgh, Pennsylvania, USA.
• ²⁴ Department of Clinical Sciences and Rheumatology, Lund University, Lund, Sweden.
• ²⁵ Lanarkshire Centre for Rheumatology, Hairmyres Hospital, East Kilbride, UK.
• ²⁶ Unit for Clinical Therapy Research (CliTRID), Karolinska Institute, Stockholm, Sweden.
• ²⁷ Josep Font Autoimmune Diseases Laboratory, IDIBAPS, Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Spain.
• ²⁸ Autoimmune Diseases Research Unit, Department of Internal Medicine, BioCruces Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Barakaldo, Spain.
• ²⁹ Division of Rheumatology, Emory University School of Medicine, Atlanta, Georgia, USA.
• ³⁰ University of California San Diego School of Medicine, La Jolla, California, USA.
• ³¹ Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey.
• ³² Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
• ³³ Department of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
• ³⁴ Copenhagen Lupus and Vasculitis Clinic, Section 4242, Center for Rheumatology and Spine Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
• ³⁵ Hospital for Joint Diseases, Seligman Centre for Advanced Therapeutics, New York University, New York City, New York, USA.
• ³⁶ Department of Rheumatology, Mount Sinai Hospital and University Health Network, University of Toronto, Toronto, Ontario, Canada.
• ³⁷ NIHR Manchester Biomedical Research Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
• ³⁸ Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health, School of Biological Sciences, The University of Manchester, Manchester, UK.
• ³⁹ Centre de Reference Maladies Auto-immunes et Systemiques Rares, Service de Medecine Interne, Hospital Cochin, Paris, France.
• ⁴⁰ Division of Rheumatology, McGill University Health Centre, Montreal, Quebec, Canada evelyne.vinet@mcgill.ca.